Resumen ejecutivo: Enfermedad por hígado graso no alcohólico en sujetos con diabetes mellitus tipo 2: Postura conjunta de la Asociación Chilena de Hepatología (ACHHEP) y la Sociedad Chilena de Diabetología (SOCHIDIAB)
-
Juan Pablo Arab ; Lorena Castro ; Patricia C. Gómez ; Paulina Vignolo ; Marco Arrese ; Francisco Barrera ; Fabiola Castro ; Luis Antonio Díaz ; Anibal Donoso ; Karina Elgueta ; Katherine González ; María Isabel González ; Manuel Moreno ; Raúl Lazarte [1] ; Jaime Poniachik ; Patricio Salman ; Juan Patricio Valderas
-
[1] Universidad de Chile
Universidad de Chile
Santiago, Chile
-
- Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 149, Nº. 9, 2021, págs. 1360-1371
- Idioma: español
- Títulos paralelos:
- Non-alcoholic fatty liver disease in type 2 diabetes: a joint statement of the Chilean Hepatology and Diabetology Societies
- Enlaces
-
Resumen
Non-alcoholic fatty liver disease (NAFLD) has a high prevalence and risk of progression to cirrhosis and other complications in patients with type 2 diabetes mellitus (T2DM). Likewise, the presence of NAFLD implies a high risk of developing T2DM, determining a bidirectional relationship between them. The diabetology and hepatology societies, developed a joint initiative aiming to unify criteria, reviewing the definitions, diagnostic criteria, risk stratification, treatment, and follow-up of patients with NAFLD and T2DM. The key questions to be discussed were defined by a panel of specialists in diabetology and hepatology. The Delphi methodology was used to reach consensus on the respective recommendations. Based on the discussion generated among the experts, diagnostic and treatment algorithms were proposed, as well as an indication for referral and the role of the different specialists involved in the management of these patients. Strengthening multidisciplinary work with patients with NAFLD and T2DM will allow the early recognition of the disease, the prevention of the progression to cirrhosis, and reducing the associated complications.
